Search Browse Earnings

VERU INC. — SlamSEC

VERU INC.

Nasdaq:VERU

Pharmaceutical Preparations·MIAMI, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$16.3M

-58.6% YoY

FY 2024

Adj. EBITDA

-$35.9M

-220.3% margin

FY 2025

Net Income

-$37.8M

-232.0% margin

FY 2025

EPS (Diluted)

-$1.05

FY 2023

Stock Price

$2.46

-0.8%

2026-03-09

52W Range

$2.10 – $7.40

P/E Ratio

-2.3x

Market Cap

$39.5M

Cash

$24.9M

FY 2025

Total Debt

$1.8M

FY 2018

Net Cash

$23.2M

FY 2018

Enterprise Value

$16.3M

Debt / EBITDA

0.6x

FY 2024

EV / EBITDA

-0.5x

Employees

—

CEO

Steiner Mitchell Shuster

CFO

Greco Michele